Fingerprint
Dive into the research topics of 'A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy for unresectable head and neck cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy for unresectable head and neck cancer
M. MacHtay, V. Aviles, M. M. Kligerman, J. Treat, G. S. Weinstein, R. S. Weber, N. Mirza, A. A. Chalian, D. I. Rosenthal
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations